Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyue Qiu

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 27, 2026
Benign vs. malignant pulmonary nodules: pleural adhesion risks and predictorsJiaheng Zhang, Keyue Qiu, Hang Chen, et al.
Plos One|May 22, 2026
Exploratory research on drugs after lung surgery based on real-world data from the FDA adverse event reporting system databaseQiaoling Pan, Hang Chen, Hanbo Pan, et al.
Scientific Reports|July 2, 2025
A deep learning-based computed tomography reading system for the diagnosis of lung cancer associated with cystic airspacesZeyang Hu, Xia Zhang, Jinqiu Yang, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 11, 2026
RBM15/IGF2BP2-PTPRH m6A regulatory axis in non-small cell lung cancerKeyue Qiu, Xiaoxiao Zheng, Hongxiang Li, et al.
Oncogene|November 11, 2024
RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1Hongxiang Li, Yin Li, Xiaoxiao Zheng, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 27, 2026
Benign vs. malignant pulmonary nodules: pleural adhesion risks and predictorsJiaheng Zhang, Keyue Qiu, Hang Chen, et al.
Plos One|May 22, 2026
Exploratory research on drugs after lung surgery based on real-world data from the FDA adverse event reporting system databaseQiaoling Pan, Hang Chen, Hanbo Pan, et al.
Scientific Reports|July 2, 2025
A deep learning-based computed tomography reading system for the diagnosis of lung cancer associated with cystic airspacesZeyang Hu, Xia Zhang, Jinqiu Yang, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 11, 2026
RBM15/IGF2BP2-PTPRH m6A regulatory axis in non-small cell lung cancerKeyue Qiu, Xiaoxiao Zheng, Hongxiang Li, et al.
Oncogene|November 11, 2024
RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1Hongxiang Li, Yin Li, Xiaoxiao Zheng, et al.
Pageof 1